Format
Sort by
Items per page

Send to

Choose Destination

Best matches for S. Güniz Küçükgüzel:

Recent advances in bioactive pyrazoles. Küçükgüzel ŞG et al. Eur J Med Chem. (2015)

Synthesis of pro-apoptotic indapamide derivatives as anticancer agents. Yılmaz Ö et al. J Enzyme Inhib Med Chem. (2015)

Synthesis of Tolmetin Hydrazide-Hydrazones and Discovery of a Potent Apoptosis Inducer in Colon Cancer Cells. Küçükgüzel ŞG et al. Arch Pharm (Weinheim). (2015)

Search results

Items: 1 to 20 of 24

1.

Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors.

Coşkun GP, Djikic T, Hayal TB, Türkel N, Yelekçi K, Şahin F, Küçükgüzel ŞG.

Molecules. 2018 Aug 6;23(8). pii: E1969. doi: 10.3390/molecules23081969.

2.

Synthesis, anticancer activity, and molecular modeling of etodolac-thioether derivatives as potent methionine aminopeptidase (type II) inhibitors.

Çoruh I, Çevik Ö, Yelekçi K, Djikic T, Küçükgüzel ŞG.

Arch Pharm (Weinheim). 2018 Apr;351(3-4):e1700195. doi: 10.1002/ardp.201700195. Epub 2018 Mar 25.

PMID:
29575045
3.

A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells.

Keogh A, Şenkardeş S, Idle JR, Küçükgüzel ŞG, Beyoğlu D.

Metabolites. 2017 Jun 2;7(2). pii: E23. doi: 10.3390/metabo7020023.

4.

Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents.

Küçükgüzel ŞG, Coşkun GP.

Anticancer Agents Med Chem. 2016;16(10):1288-300. Review.

PMID:
26899188
5.

Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.

Şenkardeş S, Kaushik-Basu N, Durmaz İ, Manvar D, Basu A, Atalay R, Küçükgüzel ŞG.

Eur J Med Chem. 2016 Jan 27;108:301-308. doi: 10.1016/j.ejmech.2015.10.041. Epub 2015 Oct 28.

PMID:
26695731
6.

Synthesis of Diflunisal Thiazolidinones as Anticancer Agents.

Şenkardeş S, Özakpınar ÖB, Özsavcı D, Şener A, Çevik Ö, Küçükgüzel ŞG.

Anticancer Agents Med Chem. 2016;16(10):1266-74.

PMID:
26320814
7.

Synthesis of Tolmetin Hydrazide-Hydrazones and Discovery of a Potent Apoptosis Inducer in Colon Cancer Cells.

Küçükgüzel ŞG, Koç D, Çıkla-Süzgün P, Özsavcı D, Bingöl-Özakpınar Ö, Mega-Tiber P, Orun O, Erzincan P, Sağ-Erdem S, Şahin F.

Arch Pharm (Weinheim). 2015 Oct;348(10):730-42. doi: 10.1002/ardp.201500178. Epub 2015 Aug 19.

PMID:
26287512
8.

Synthesis of pro-apoptotic indapamide derivatives as anticancer agents.

Yılmaz Ö, Özbaş Turan S, Akbuğa J, Tiber PM, Orun O, Supuran CT, Küçükgüzel ŞG.

J Enzyme Inhib Med Chem. 2015 Dec;30(6):967-80. doi: 10.3109/14756366.2014.1001756. Epub 2015 Sep 4.

PMID:
25683085
9.

Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles.

Çıkla-Süzgün P, Kaushik-Basu N, Basu A, Arora P, Talele TT, Durmaz I, Çetin-Atalay R, Küçükgüzel ŞG.

J Enzyme Inhib Med Chem. 2015;30(5):778-85. doi: 10.3109/14756366.2014.971780.

PMID:
25676325
10.

Recent advances bioactive 1,2,4-triazole-3-thiones.

Küçükgüzel ŞG, Çıkla-Süzgün P.

Eur J Med Chem. 2015 Jun 5;97:830-70. doi: 10.1016/j.ejmech.2014.11.033. Epub 2014 Nov 26. Review.

PMID:
25563511
11.

Recent advances in bioactive pyrazoles.

Küçükgüzel ŞG, Şenkardeş S.

Eur J Med Chem. 2015 Jun 5;97:786-815. doi: 10.1016/j.ejmech.2014.11.059. Epub 2014 Dec 5. Review.

PMID:
25555743
12.

Synthesis, cytotoxicity, and pro-apoptosis activity of etodolac hydrazide derivatives as anticancer agents.

Çıkla P, Özsavcı D, Bingöl-Özakpınar Ö, Şener A, Çevik Ö, Özbaş-Turan S, Akbuğa J, Şahin F, Küçükgüzel ŞG.

Arch Pharm (Weinheim). 2013 May;346(5):367-79. doi: 10.1002/ardp.201200449. Epub 2013 Apr 22.

PMID:
23609809
13.

Synthesis and characterization of celecoxib derivatives as possible anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV agents.

Küçükgüzel ŞG, Coşkun İ, Aydın S, Aktay G, Gürsoy Ş, Çevik Ö, Özakpınar ÖB, Özsavcı D, Şener A, Kaushik-Basu N, Basu A, Talele TT.

Molecules. 2013 Mar 21;18(3):3595-614. doi: 10.3390/molecules18033595.

14.

Medicinal chemistry and anti-inflammatory activity of nitric oxide-releasing NSAI drugs.

Koç And E, Küçükgüzel SG.

Mini Rev Med Chem. 2009 May;9(5):611-9. Review.

PMID:
19456291
15.

4-Thiazolidinones: a novel class of hepatitis C virus NS5B polymerase inhibitors.

Kaushik-Basu N, Bopda-Waffo A, Talele TT, Basu A, Chen Y, Kucukguzel SG.

Front Biosci. 2008 May 1;13:3857-68.

PMID:
18508480
16.

HPLC analysis of in vivo metabolites of 4-nitrobenzoic acid [(5-nitro-2-thiopheneyl)methylene]hydrazide in rats.

Koçyiğit-Kaymakçioğlu B, Unsalan S, Küçükgüzel SG, Sener G, Rollas S.

Eur J Drug Metab Pharmacokinet. 2007 Oct-Dec;32(4):197-203.

PMID:
18348468
17.

Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms.

Karakuş S, Küçükgüzel I, Küçükgüzel SG.

J Pharm Biomed Anal. 2008 Jan 22;46(2):295-302. Epub 2007 Oct 22.

PMID:
18054459
18.

Biological activities of hydrazone derivatives.

Rollas S, Küçükgüzel SG.

Molecules. 2007 Aug 17;12(8):1910-39. Review.

19.
20.

Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents.

Küçükgüzel SG, Küçükgüzel I, Tatar E, Rollas S, Sahin F, Güllüce M, De Clercq E, Kabasakal L.

Eur J Med Chem. 2007 Jul;42(7):893-901. Epub 2007 Feb 25.

PMID:
17418454

Supplemental Content

Loading ...
Support Center